Daré Bioscience, Inc. DARE

HC Wainwright & Co. Maintains Buy on Dare Bioscience, Raises Price Target to $6

https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6 https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6

Analyst Forecast
According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 6.12, which is an increase of 247.73% from the latest price.

Price Target
$6.12
(247.73% upside)
Analyst Consensus: Buy

Stock Price Forecast
The 5 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 6.00, with a high estimate of 17.00 and a low estimate of 3.00. The median estimate represents a +248.84% increase from the last price of 1.72.
Analyst Recommendations
The current consensus among 5 polled investment analysts is to buy stock in Dare Bioscience Inc. This rating has held steady since January, when it was unchanged from a buy rating.
Move your mouse over past
months for detail

Earnings and Sales Forecasts
Current QuarterEarnings per Share
-$0.14Sales
$437.8KREPORTING Date
May 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -29.55%

Growthannually 22.54%

Sales

Growthquarterly --

Growthannually --

Key to the earnings and sales forecast charts.

U.S

Crime + Justice
Energy + Environment
Extreme Weather
Space + Science
World

Africa
Americas
Asia
Australia
Europe
Middle East
UK
Politics

45
Congress
Supreme Court
2018
Key Races
Primary Results
Business

Markets
Tech
Media
Success
Video
Opinion

Political Op-Eds
Social Commentary
Health

Food
Fitness
Wellness
Parenting
Vital Signs
Entertainment

Stars
Screen
Binge
Culture
Media
Tech

Innovate
Gadget
Mission: Ahead
Upstarts
Innovative Cities
Style

Arts
Design
Fashion
Architecture
Luxury
Autos
Video
Travel

Destinations
Food & Drink
Play
Stay
Videos
Sports

Pro Football
College Football
Basketball
Baseball
Soccer
Olympics
Video

Live TV
Digital Studios
CNN Films
HLNTV
Schedule
TV Shows A-Z
CNNVR
Shop

CNN Underscored
-Explore
-Wellness
-Gadgets
-Lifestyle
CNN Store
More...

Photos
Longform
Investigations
CNN Profiles
CNN Leadership
CNN Newsletters
Work for CNN

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc.2019. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates.

© 2021 Cable News Network. A Warner Media Company. All Rights Reserved.
CNN Sans™ & © 2016 Cable News Network.

Newsletters
Contact Us
Terms of Use
Privacy Policy
Do Not Sell My Personal Information
Accessibiliy & CC
AdChoices

According to 11 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is 6.12, which is an increase of 275.46% from the latest price.

Price Target
$6.12
(275.46% upside)
Analyst Consensus: Buy

HC Wainwright & Co. Maintains Buy on Dare Bioscience, Raises Price Target to $6

https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6 https://www.benzinga.com/news/22/04/26421858/hc-wainwright-co-maintains-buy-on-dare-bioscience-raises-price-target-to-6

Daré Bioscience (NASDAQ:DARE) PT Raised to $17.00 at Roth Capital
Daré Bioscience logoDaré Bioscience (NASDAQ:DARE - Get Rating) had its price target hoisted by equities researchers at Roth Capital from $11.00 to $17.00 in a note issued to investors on Friday, The Fly reports.

Several other brokerages have also commented on

https://www.marketbeat.com/instant-alerts/nasdaq-dare-a-buy-or-sell-right-now-2022-04/

https://finance.yahoo.com/news/dar-bioscience-present-maxim-2022-120000983.html

https://ir.darebioscience.com/events-presentations

Question : can DARE beats estimates on earning in 9 days ??